Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 9/20 | 0.95 |
| ▸ | FAAH | O00519 | 5/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.56 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9643398 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL30009171 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL15483488 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL15082420 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL140275 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL349749 | 0.97 | MGLL (1.00) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL19708788 | 0.93 | MGLL (0.83) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL14996140 | 0.91 | MGLL (0.79) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL44460 | 0.89 | MGLL (0.76) | MGLLFAAHALDH1A1LMNAMAPT | |
| SCHEMBL15856167 | 0.89 | MGLL (0.76) | MGLLFAAHALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113980631-A | Reactive polyurethane hot melt adhesive and preparation method thereof | 烟台德邦科技股份有限公司 | 2022-01-28 | — | — | CN | claimed |
| US-20240050587-A1 | LIPOSOMES COMPRISING ANTI-LOX ANTIBODY | ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI "DINO AMADORI" - IRST S.R.L. (IT) | 2024-02-15 | — | — | US | disclosed |
| EP-4037718-A1 | LIPOSOMES COMPRISING ANTI-LOX ANTIBODY | Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori (I.R.S.T.) S.R.L. (IT) | 2022-08-10 | — | — | EP | disclosed |
| WO-2016143647-A1 | PROCESS FOR PRODUCING LOW-CONCENTRATION GEL USING GEL-PRECURSOR CLUSTERS, AND GEL OBTAINED BY SAID PRODUCTION PROCESS | 国立大学法人 東京大学 | 2016-09-15 | — | — | WO | disclosed |
| US-9267005-B2 | Flexible maleimide polymer and method for preparing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-02-23 | — | — | US | disclosed |
| US-8895759-B2 | Intermediates useful in the preparation of maleimide functionalized polymers | NEKTAR THERAPEUTICS (US) | 2014-11-25 | — | — | US | disclosed |
| US-20140309168-A1 | MODIFIED PEPTIDES AND PROTEINS | AMIDEBIO, LLC (US) | 2014-10-16 | — | — | US | disclosed |
| US-20140155457-A1 | Method of Relieving, Improving, Preventing or Treating Xerostomia | SUNBIO INC. (KR) | 2014-06-05 | — | — | US | disclosed |
| US-20140128619-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2014-05-08 | — | — | US | disclosed |
| US-8653286-B2 | Intermediates useful in the preparation of maleimide functionalized polymers | NEKTAR THERAPEUTICS (US) | 2014-02-18 | — | — | US | disclosed |
| US-8258324-B2 | Intermediates useful in the preparation of maleimide functionalized polymers | NEKTAR THERAPEUTICS (US) | 2012-09-04 | — | — | US | disclosed |
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | INNOTHERAPY INC. (KR) | 2012-03-15 | — | — | US | disclosed |
| US-20120004422-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2012-01-05 | — | — | US | disclosed |
| US-8039579-B2 | Intermediates useful in the preparation of maleimide functionalized polymers | NEKTAR THERAPEUTICS (US) | 2011-10-18 | — | — | US | disclosed |
| US-20100261841-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | NEKTAR THERAPEUTICS (US) | 2010-10-14 | — | — | US | disclosed |
| US-7790835-B2 | Water soluble, non-peptidic polymer covalently attached to a Diels-Alder bicyclic or tricyclic imide ring; chemical intermediates | NEKTAR THERAPEUTICS (US) | 2010-09-07 | — | — | US | disclosed |
| EP-2114998-A1 | NOVEL MULTIMERIC MOLECULES, METHOD FOR PREPARING SAME AND USE THEREOF IN THE PREPARATION OF DRUGS | Centre National de la Recherche Scientifique (FR) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008110695-A1 | NOVEL MULTIMERIC MOLECULES, METHOD FOR PREPARING SAME AND USE THEREOF IN THE PREPARATION OF DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-09-18 | — | — | WO | disclosed |
| EP-0975669-A1 | CALCITONIN RECEPTOR-BINDING PEPTIDES | Diatide, Inc. (US) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998049196-A1 | CALCITONIN RECEPTOR-BINDING PEPTIDES | DIATIDE, INC. (US) | 1998-11-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155457-A1 | Method of Relieving, Improving, Preventing or Treating Xerostomia | GLA, LPO, MUC1 | MGLL 239/4885FAAH 930/4885ALDH1A1 2041/4885 |
| US-20120064061-A1 | ADHESIVE COMPOSITION COMPRISING TANNIN, POLY(ETHYLENE GLYCOL), AND WATER, LOWER ALCOHOL OR MIXTURE THEREOF | EPCAM, ICAM1, VCAM1 | MGLL 352/4885FAAH 260/4885ALDH1A1 620/4885 |
| US-20140128619-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | DERA, MMAB, PAICS | MGLL 3710/4885FAAH 4109/4885ALDH1A1 74/4885 |
| US-20120004422-A1 | Intermediates Useful in the Preparation of Maleimide Functionalized Polymers | DERA, MMAB, PAICS | MGLL 3710/4885FAAH 4109/4885ALDH1A1 74/4885 |
| US-20140309168-A1 | MODIFIED PEPTIDES AND PROTEINS | IAPP, VIP, ENPEP | MGLL 2869/4885FAAH 2984/4885ALDH1A1 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.